• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Is conservative organ-sparing treatment of penile carcinoma justified?

作者信息

Gotsadze D, Matveev B, Zak B, Mamaladze V

机构信息

Department of Urology, Oncological Research Center, Georgia, Tbilisi, Georgia, USA.

出版信息

Eur Urol. 2000 Sep;38(3):306-12. doi: 10.1159/000020298.

DOI:10.1159/000020298
PMID:10940705
Abstract

PURPOSE

The results of different conservative organ-sparing methods - radiotherapy, chemotherapy and radiochemotherapy - in the treatment of penile carcinoma were studied.

MATERIALS AND METHODS

Conservatively treated 223 patients with penile carcinoma seen in three hospitals between 1959 and 1996 years were studied retrospectively. Among them 155 received radiotherapy, 33 chemotherapy, and 35 radiochemotherapy.

RESULTS

The local control was achieved in 135 (60.5%) of 223 patients. The difference in local control rate among these three groups of patients has not reached statistical significance. The efficacy of conservative treatment was highly associated with three factors: tumor size, grade and patient's age. Overall, 24 of 135 patients (17.7%) had local recurrence. Ten patients (4.5%) developed regional metastases. The recurrence rate did not correlate with tumor size and grade and was similar for all treatment modalities. Long-term results of each method were approximatley equal and 5-year survival varied from 78 to 88%.

CONCLUSION

Conservative organ-sparing treatment of early-stage penile carcinomas is justified. Failure should be corrected by surgery without compromising survival.

摘要

相似文献

1
Is conservative organ-sparing treatment of penile carcinoma justified?
Eur Urol. 2000 Sep;38(3):306-12. doi: 10.1159/000020298.
2
Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control.阴茎鳞癌的保守手术:切缘和长期肿瘤控制。
J Urol. 2012 Sep;188(3):803-8. doi: 10.1016/j.juro.2012.05.012. Epub 2012 Jul 19.
3
A 10-year retrospective audit of penile cancer management in the UK.英国阴茎癌治疗的10年回顾性审计
BJU Int. 2007 Dec;100(6):1277-81. doi: 10.1111/j.1464-410X.2007.07168.x. Epub 2007 Sep 10.
4
Long-term outcome of excisional organ sparing surgery for carcinoma of the penis.阴茎癌根治性切除术的长期疗效。
J Urol. 2011 Oct;186(4):1303-7. doi: 10.1016/j.juro.2011.05.084.
5
Treatment of penile carcinoma: to cut or not to cut?阴茎癌的治疗:切还是不切?
Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):674-9. doi: 10.1016/j.ijrobp.2006.05.053. Epub 2006 Sep 1.
6
Organ-sparing treatment of penile cancer with interstitial pulsed-dose-rate brachytherapy.阴茎癌的组织间脉冲剂量率近距离放射治疗保器官治疗
Strahlenther Onkol. 2016 Jul;192(7):467-72. doi: 10.1007/s00066-016-0968-x. Epub 2016 Jun 9.
7
[Organ-preserving treatment in cancer of the penis].阴茎癌的保留器官治疗
Urol Nefrol (Mosk). 1995 Nov-Dec(6):44-7.
8
Organ-sparing treatment for penile cancer.阴茎癌的保留器官治疗。
Nat Clin Pract Urol. 2007 Nov;4(11):596-604. doi: 10.1038/ncpuro0918.
9
Multi-institutional long-term experience with conservative surgery for invasive penile carcinoma.多机构关于浸润性阴茎癌保守手术的长期经验。
J Urol. 2003 Feb;169(2):500-2. doi: 10.1097/01.ju.0000043808.58188.52.
10
The role of radiation therapy after incomplete resection of penile cancer.阴茎癌不完全切除术后放射治疗的作用。
Strahlenther Onkol. 2008 Jul;184(7):359-63. doi: 10.1007/s00066-008-1818-2. Epub 2008 Oct 1.

引用本文的文献

1
The role of radiotherapy in the management of squamous cell cancer of the penis.放疗在阴茎鳞状细胞癌治疗中的作用。
World J Urol. 2023 Dec;41(12):3913-3920. doi: 10.1007/s00345-023-04683-7. Epub 2023 Nov 23.
2
Updates in the use of radiotherapy in the management of primary and locally-advanced penile cancer.原发性和局部晚期阴茎癌治疗中放射治疗应用的进展
Asian J Urol. 2022 Oct;9(4):389-406. doi: 10.1016/j.ajur.2022.05.010. Epub 2022 Sep 9.
3
What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes.
侵袭性阴茎癌男性患者原发性肿瘤的最有效管理方法是什么:对可用治疗方案及其结果的系统评价
Eur Urol Open Sci. 2022 May 2;40:58-94. doi: 10.1016/j.euros.2022.04.002. eCollection 2022 Jun.
4
Penile sparing therapy for penile cancer.阴茎癌的保留阴茎治疗
Transl Androl Urol. 2020 Dec;9(6):3195-3209. doi: 10.21037/tau.2019.08.07.
5
Survival Following Salvage Surgery after Failed Radiotherapy for Penile Cancer: A SEER-Based Study.阴茎癌放疗失败后挽救性手术后的生存情况:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Curr Urol. 2019 May 10;12(3):142-146. doi: 10.1159/000489432.
6
Penile-sparing modalities in the management of low-stage penile cancer.低分期阴茎癌治疗中的保留阴茎方法
Urol Ann. 2018 Jan-Mar;10(1):1-6. doi: 10.4103/UA.UA_93_17.
7
Penile sparing surgical approaches for primary penile tumors: preserving function and appearance.原发性阴茎肿瘤的保留阴茎手术方法:保留功能与外观。
Transl Androl Urol. 2017 Oct;6(5):809-819. doi: 10.21037/tau.2017.04.01.
8
Organ Preservation Surgery for Carcinoma Penis.阴茎癌的器官保留手术
Indian J Surg Oncol. 2017 Mar;8(1):59-63. doi: 10.1007/s13193-016-0573-6. Epub 2016 Dec 20.
9
Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients).早期阴茎癌的低剂量近距离放射治疗:一项为期20年的单机构研究(73例患者)。
Radiat Oncol. 2016 Jul 27;11:96. doi: 10.1186/s13014-016-0676-9.
10
Penile preserving and reconstructive surgery in the management of penile cancer.阴茎癌的保阴茎和重建手术治疗。
Nat Rev Urol. 2016 May;13(5):249-57. doi: 10.1038/nrurol.2016.54. Epub 2016 Mar 22.